Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib

Detalles Bibliográficos
Autores principales: Kim, Sa Rang, Charos, Alexandra, Damsky, William, Heald, Peter, Girardi, Michael, King, Brett A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031588/
https://www.ncbi.nlm.nih.gov/pubmed/29984277
http://dx.doi.org/10.1016/j.jdcr.2017.12.003
_version_ 1783337338051493888
author Kim, Sa Rang
Charos, Alexandra
Damsky, William
Heald, Peter
Girardi, Michael
King, Brett A.
author_facet Kim, Sa Rang
Charos, Alexandra
Damsky, William
Heald, Peter
Girardi, Michael
King, Brett A.
author_sort Kim, Sa Rang
collection PubMed
description
format Online
Article
Text
id pubmed-6031588
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-60315882018-07-06 Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib Kim, Sa Rang Charos, Alexandra Damsky, William Heald, Peter Girardi, Michael King, Brett A. JAAD Case Rep Case Report Elsevier 2018-04-30 /pmc/articles/PMC6031588/ /pubmed/29984277 http://dx.doi.org/10.1016/j.jdcr.2017.12.003 Text en © 2017 Elsevier Inc. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Kim, Sa Rang
Charos, Alexandra
Damsky, William
Heald, Peter
Girardi, Michael
King, Brett A.
Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib
title Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib
title_full Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib
title_fullStr Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib
title_full_unstemmed Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib
title_short Treatment of generalized deep morphea and eosinophilic fasciitis with the Janus kinase inhibitor tofacitinib
title_sort treatment of generalized deep morphea and eosinophilic fasciitis with the janus kinase inhibitor tofacitinib
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031588/
https://www.ncbi.nlm.nih.gov/pubmed/29984277
http://dx.doi.org/10.1016/j.jdcr.2017.12.003
work_keys_str_mv AT kimsarang treatmentofgeneralizeddeepmorpheaandeosinophilicfasciitiswiththejanuskinaseinhibitortofacitinib
AT charosalexandra treatmentofgeneralizeddeepmorpheaandeosinophilicfasciitiswiththejanuskinaseinhibitortofacitinib
AT damskywilliam treatmentofgeneralizeddeepmorpheaandeosinophilicfasciitiswiththejanuskinaseinhibitortofacitinib
AT healdpeter treatmentofgeneralizeddeepmorpheaandeosinophilicfasciitiswiththejanuskinaseinhibitortofacitinib
AT girardimichael treatmentofgeneralizeddeepmorpheaandeosinophilicfasciitiswiththejanuskinaseinhibitortofacitinib
AT kingbretta treatmentofgeneralizeddeepmorpheaandeosinophilicfasciitiswiththejanuskinaseinhibitortofacitinib

Ejemplares similares